Ishihara, N.; Nishimura, N.; Ikawa, K.; Karino, F.; Miura, K.; Tamaki, H.; Yano, T.; Isobe, T.; Morikawa, N.; Naora, K.
Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia. Antibiotics 2020, 9, 113.
https://doi.org/10.3390/antibiotics9030113
AMA Style
Ishihara N, Nishimura N, Ikawa K, Karino F, Miura K, Tamaki H, Yano T, Isobe T, Morikawa N, Naora K.
Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia. Antibiotics. 2020; 9(3):113.
https://doi.org/10.3390/antibiotics9030113
Chicago/Turabian Style
Ishihara, Noriyuki, Nobuhiro Nishimura, Kazuro Ikawa, Fumi Karino, Kiyotaka Miura, Hiroki Tamaki, Takahisa Yano, Takeshi Isobe, Norifumi Morikawa, and Kohji Naora.
2020. "Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia" Antibiotics 9, no. 3: 113.
https://doi.org/10.3390/antibiotics9030113
APA Style
Ishihara, N., Nishimura, N., Ikawa, K., Karino, F., Miura, K., Tamaki, H., Yano, T., Isobe, T., Morikawa, N., & Naora, K.
(2020). Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia. Antibiotics, 9(3), 113.
https://doi.org/10.3390/antibiotics9030113